SB1250 - Drug-price Transparency for Consumers Act of 2023
US Congress - 118th Congress
Last updated over 1 year ago
0 Co-Sponsors
A bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information.
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now